BRPI0909749A2 - uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea - Google Patents

uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea

Info

Publication number
BRPI0909749A2
BRPI0909749A2 BRPI0909749-0A BRPI0909749A BRPI0909749A2 BR PI0909749 A2 BRPI0909749 A2 BR PI0909749A2 BR PI0909749 A BRPI0909749 A BR PI0909749A BR PI0909749 A2 BRPI0909749 A2 BR PI0909749A2
Authority
BR
Brazil
Prior art keywords
photoinitiator
strengthening
ectasia
corneal
keratoconus
Prior art date
Application number
BRPI0909749-0A
Other languages
English (en)
Inventor
Dewoolfson Bruce
Devore Dale
Original Assignee
Euclid Systems Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euclid Systems Corporation filed Critical Euclid Systems Corporation
Publication of BRPI0909749A2 publication Critical patent/BRPI0909749A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)

Abstract

uso de fotoiniciador para o fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea. são descritos métodos de fortalecimento das propriedades 5 biomecânicas da córnea expondo a córnea à luz ultravioleta na presença de um fotoiniciador. estes métodos podem ser usados para tratar o ceratocone. podem também ser usados para tratar a ectasia a seguir a um procedimento cirúrgico ou fortalecer a córnea antes de um procedimento cirúrgico.
BRPI0909749-0A 2008-03-14 2009-03-10 uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea BRPI0909749A2 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US6460008P 2008-03-14 2008-03-14
US61/064,600 2008-03-14
US6486408P 2008-03-31 2008-03-31
US61/064,864 2008-03-31
US7158008P 2008-05-07 2008-05-07
US61/071,580 2008-05-07
PCT/US2009/036636 WO2009114513A2 (en) 2008-03-14 2009-03-10 Ultraviolet irradiation to treat corneal weakness disorders

Publications (1)

Publication Number Publication Date
BRPI0909749A2 true BRPI0909749A2 (pt) 2019-02-26

Family

ID=41065787

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909749-0A BRPI0909749A2 (pt) 2008-03-14 2009-03-10 uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea

Country Status (10)

Country Link
US (1) US20110060267A1 (pt)
EP (1) EP2265233A2 (pt)
JP (1) JP2011514359A (pt)
KR (1) KR20110018295A (pt)
CN (1) CN101969900A (pt)
AU (1) AU2009223641A1 (pt)
BR (1) BRPI0909749A2 (pt)
CA (1) CA2715031A1 (pt)
MX (1) MX2010009923A (pt)
WO (1) WO2009114513A2 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110098790A1 (en) * 2009-10-26 2011-04-28 Albert Daxer Methods for treating corneal disease
US11246951B2 (en) * 2005-01-31 2022-02-15 S. Edward Neister Method and apparatus for sterilizing and disinfecting air and surfaces and protecting a zone from external microbial contamination
BRPI0712009A2 (pt) 2006-05-23 2012-02-14 Daxer Albert implante de córnea e processo para corrigir problemas de visão do olho humano
US9707126B2 (en) 2009-10-21 2017-07-18 Avedro, Inc. Systems and methods for corneal cross-linking with pulsed light
US8574277B2 (en) 2009-10-21 2013-11-05 Avedro Inc. Eye therapy
JP6377906B2 (ja) 2010-03-19 2018-08-22 アヴェドロ・インコーポレーテッドＡｖｅｄｒｏ，Ｉｎｃ． 眼治療を適用およびモニターするためのシステム
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
US9044308B2 (en) * 2011-05-24 2015-06-02 Avedro, Inc. Systems and methods for reshaping an eye feature
US9020580B2 (en) 2011-06-02 2015-04-28 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
WO2013028833A1 (en) 2011-08-23 2013-02-28 Anthony Natale Systems and methods for treating pathogenic infection
US9023092B2 (en) 2011-08-23 2015-05-05 Anthony Natale Endoscopes enhanced with pathogenic treatment
EP2830637A4 (en) 2012-03-29 2016-03-16 Cxl Ophthalmics Llc COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING DISEASES RELATED TO OXIDATIVE STRESS
WO2013148895A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
WO2013148896A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular treatment solutions, delivery devices and delivery augmentation methods
EP3858356A3 (en) * 2013-05-19 2021-12-01 Avedro, Inc. Systems, methods, and compositions for cross-linking
WO2014205145A1 (en) 2013-06-18 2014-12-24 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
RU2542799C1 (ru) * 2013-10-29 2015-02-27 Игорь Борисович Медведев Способ лечения кератоконуса роговицы
KR102545628B1 (ko) 2014-10-27 2023-06-20 아베드로 인코퍼레이티드 눈의 교차-결합 처리를 위한 시스템 및 방법
WO2016077747A1 (en) 2014-11-13 2016-05-19 Avedro, Inc. Multipass virtually imaged phased array etalon
WO2016172695A1 (en) 2015-04-24 2016-10-27 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
WO2016191342A1 (en) 2015-05-22 2016-12-01 Avedro, Inc. Systems and methods for monitoring cross-linking activity for corneal treatments
US11207410B2 (en) 2015-07-21 2021-12-28 Avedro, Inc. Systems and methods for treatments of an eye with a photosensitizer
CN113304390B (zh) 2015-12-03 2024-03-08 艾维德洛公司 利用面罩装置处理眼睛的系统和方法
WO2017180851A1 (en) 2016-04-13 2017-10-19 Avedro, Inc. Systems and methods for delivering drugs to an eye
WO2019070979A1 (en) * 2017-10-04 2019-04-11 University Of Florida Research Foundation METHODS AND COMPOSITIONS FOR ENHANCED COMFORT CONTACT LENS
US11766356B2 (en) 2018-03-08 2023-09-26 Avedro, Inc. Micro-devices for treatment of an eye
CN108693267B (zh) * 2018-05-18 2020-12-08 中国烟草总公司郑州烟草研究院 4-甲基二苯甲酮纯度标准物质及其制备方法
CA3147045A1 (en) 2019-08-06 2021-02-11 Desmond C. Adler Photoactivation systems and methods for corneal cross-linking treatments
US11259959B1 (en) 2020-11-03 2022-03-01 D&D Biopharmaceuticals, Inc. Devices and methods for cornea treatment
US11938092B1 (en) 2022-11-30 2024-03-26 D&D Biopharmaceuticals, Inc. Devices and methods for cornea treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4969912A (en) * 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US5067961A (en) * 1988-02-18 1991-11-26 Autogenesis Technologies, Inc. Non-biodegradable two phase corneal implant and method for preparing same
US5201764A (en) * 1990-02-28 1993-04-13 Autogenesis Technologies, Inc. Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom
US5104957A (en) * 1990-02-28 1992-04-14 Autogenesis Technologies, Inc. Biologically compatible collagenous reaction product and articles useful as medical implants produced therefrom
US5219895A (en) * 1991-01-29 1993-06-15 Autogenesis Technologies, Inc. Collagen-based adhesives and sealants and methods of preparation and use thereof
US6161544A (en) * 1998-01-28 2000-12-19 Keratoform, Inc. Methods for accelerated orthokeratology
US6183498B1 (en) * 1999-09-20 2001-02-06 Devore Dale P. Methods and products for sealing a fluid leak in a tissue
KR101502632B1 (ko) * 2006-10-24 2015-03-17 캘리포니아 인스티튜트 오브 테크놀로지 신체 조직의 물리적 및/또는 화학적 성질에 영향을 주는 광화학적 요법

Also Published As

Publication number Publication date
JP2011514359A (ja) 2011-05-06
KR20110018295A (ko) 2011-02-23
AU2009223641A1 (en) 2009-09-17
MX2010009923A (es) 2010-12-17
EP2265233A2 (en) 2010-12-29
CA2715031A1 (en) 2009-09-17
US20110060267A1 (en) 2011-03-10
WO2009114513A2 (en) 2009-09-17
CN101969900A (zh) 2011-02-09
WO2009114513A3 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
BRPI0909749A2 (pt) uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
CY1116344T1 (el) Κυτταρα προερχομενα απο ιστο ομφαλιου λωρου για την θεραπεια νευροπαθητικου πονου και σπαστικοτητας
EA201000914A1 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
EA200901211A1 (ru) Антигены белка с5 и их применение
BR112019001573A2 (pt) conjunto de componentes e dispositivos para aplicação de terapia de luz e métodos relacionados aos mesmos
BR112013020005A8 (pt) peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
BR112015006623A2 (pt) laquinimod e pridopidina para o tratamento de doenças neurodegenerativas
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
CY1114577T1 (el) Αποτροπη και θεραπεια υπο-κλινικης pcvd
EA201000897A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
EA201200762A1 (ru) Применение простагландинов f2-альфа и аналогов для заживления повреждений роговицы и конъюнктивы
BR112015001158A2 (pt) formulação oftálmica e respectivo uso e método para melhorar, reduzir ou tratar presbiopia
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
BR112015018252A2 (pt) composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit
BRPI0513168A (pt) memantina como tratamento adjunto para antipsicóticos atìpicos em pacientes com esquizofrenia
NO20074850L (no) Oftalmologiske sammensetninger og anvendelse derav
CO6640335A2 (es) Tratamiento terapéutico para síndrome metabólico, diabetes de tipo 2, obesidad o prediabetes
BR112017015387A2 (pt) composição em gel tópica, método de tratamento de uma infecção da pele, composição em gel oftálmica, e, método de tratamento de uma afecção infecciosa do olho ou pálpebra
AR046892A1 (es) Suspensiones acuosas de ciclesonida para nebulizaciones y metodo de preparacion
WO2016060917A3 (en) Formulations for histatin therapeutics
BRPI0913665B8 (pt) composição para tratamento de pressão intraocular aumentada em um paciente, compreendendo extratos de vaccinum myrtillus e de casca de pinheiro
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
BR112013025197A2 (pt) métodos para tratar doença de alzheimer e para avaliar a eficáca de uma terapia destinada a tratar doença de alzheimer

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: VIDE PARECER

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]